Insider Cluster (2 insiders) ·Filed Jun 4, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $1.0M total
Actionable Insight • Neutral

Sales are routine and likely tied to option exercise tax planning. No bearish signal given the trivial dollar amount relative to market cap. Monitor for any material change in insider selling pattern, such as a sudden increase in volume or C-suite cluster without concurrent option exercises.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▼ -7.20% at T+60d
NEUTRAL call ✗ call lost -7.20% · α vs SPY -11.20% · entry $549.87 → $510.26
Entry anchored
Jun 4, 2026
via day open
T+1d
-0.94%
call -0.94% · α -1.17%
$544.69
settled 4mo ago
T+5d
-0.71%
call -0.71% · α -1.28%
$545.96
settled 4mo ago
T+20d
-0.48%
call -0.48% · α -2.34%
$547.25
settled 3mo ago
T+60d
-7.20%
call -7.20% · α -11.20%
$510.26
settled 5w ago

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and CFO James Edgemond executed derivative exercises and sold a combined ~$1.0M in open-market shares over a 3-day window. The sales are small relative to UTHR's $23.3B market cap (~0.004%), and the derivative exercises are non-cash events. The cluster is routine and lacks material directional signal.

Key Financial Metrics

Direction
selling
Total Value
$1.0M
Insiders
2

Key Facts

  • CEO Rothblatt sold 401 shares at ~$543.89 for $218K on June 3, 2026
  • CFO Edgemond sold 1,440 shares at ~$544.96 for $785K on June 1, 2026
  • Both insiders exercised stock options (non-cash) alongside the sales
  • Total open-market sales: ~$1.0M, representing ~0.004% of UTHR's $23.3B market cap
  • No open-market purchases were made by any insider in the cluster

Financial Impact

Total insider sales of ~$1.0M, immaterial relative to $23.3B market cap

insider holdings

Risk Factors

  • No material risk identified from this cluster alone
  • Historical performance on UTHR reports shows poor T+20 win rate (17%), suggesting limited predictive value from insider activity at this company

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1780605193747
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 4, 2026